Rituximab (anti-CD20 monoclonal antibody) therapy for progressive intermediate-grade non-Hodgkin’s lymphoma after high-dose therapy and autologous peripheral stem cell transplantation
Authors:
- Hcf MooreHMHcf Moore
- Cl HardyCHCl Hardy
- Dl PorterDPDl Porter
- Ey LohELEy Loh
- Dj VaughnDVDj Vaughn
- S LugerSLS Luger
- Sj SchusterSSSj Schuster
- Ea StadtmauerESEa Stadtmauer
- 1 September 1999
- journal article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 24 (5) , 521-526